154 related articles for article (PubMed ID: 28475405)
1. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
Kung CP; Liu Q; Murphy ME
Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
[TBL] [Abstract][Full Text] [Related]
2. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.
Kung CP; Khaku S; Jennis M; Zhou Y; Murphy ME
Mol Cancer Res; 2015 Feb; 13(2):250-62. PubMed ID: 25256710
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.
Zhao Y; Wu L; Yue X; Zhang C; Wang J; Li J; Sun X; Zhu Y; Feng Z; Hu W
Elife; 2018 Mar; 7():. PubMed ID: 29557783
[TBL] [Abstract][Full Text] [Related]
4. P53 codon 72 polymorphism in Taiwanese breast cancer patients.
Chen FM; Ou-Yang F; Yang SF; Tsai EM; Hou MF
Kaohsiung J Med Sci; 2013 May; 29(5):259-64. PubMed ID: 23639512
[TBL] [Abstract][Full Text] [Related]
5. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
[TBL] [Abstract][Full Text] [Related]
6. CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest.
Azzam G; Wang X; Bell D; Murphy ME
PLoS One; 2013; 8(9):e74297. PubMed ID: 24019961
[TBL] [Abstract][Full Text] [Related]
7. The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation.
Frank AK; Leu JI; Zhou Y; Devarajan K; Nedelko T; Klein-Szanto A; Hollstein M; Murphy ME
Mol Cell Biol; 2011 Mar; 31(6):1201-13. PubMed ID: 21245379
[TBL] [Abstract][Full Text] [Related]
8. Differential Transcriptional Regulation of Polymorphic p53 Codon 72 in Metabolic Pathways.
Kim BY; Lee SY; Chung SK
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639134
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction.
Tran TQ; Lowman XH; Reid MA; Mendez-Dorantes C; Pan M; Yang Y; Kong M
Oncogene; 2017 Apr; 36(14):1991-2001. PubMed ID: 27721412
[TBL] [Abstract][Full Text] [Related]
10. The Codon 72
Cho JH; Patel B; Bonala S; Mansouri H; Manne S; Vadrevu SK; Ghouse S; Kung CP; Murphy ME; Astrinidis A; Henske EP; Kwiatkowski DJ; Markiewski MM; Karbowniczek M
Mol Cancer Res; 2019 Aug; 17(8):1639-1651. PubMed ID: 31088907
[TBL] [Abstract][Full Text] [Related]
11. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
12. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.
Maddocks OD; Berkers CR; Mason SM; Zheng L; Blyth K; Gottlieb E; Vousden KH
Nature; 2013 Jan; 493(7433):542-6. PubMed ID: 23242140
[TBL] [Abstract][Full Text] [Related]
13. The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.
Leu JI; Murphy ME; George DL
J Liver; 2013; 2(1):. PubMed ID: 23991369
[TBL] [Abstract][Full Text] [Related]
14. Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
De Souza C; Madden J; Koestler DC; Minn D; Montoya DJ; Minn K; Raetz AG; Zhu Z; Xiao WW; Tahmassebi N; Reddy H; Nelson N; Karnezis AN; Chien J
J Natl Cancer Inst; 2021 Sep; 113(9):1246-1257. PubMed ID: 33555293
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α.
Basu S; Gnanapradeepan K; Barnoud T; Kung CP; Tavecchio M; Scott J; Watters A; Chen Q; Kossenkov AV; Murphy ME
Genes Dev; 2018 Feb; 32(3-4):230-243. PubMed ID: 29463573
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
17. An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.
Honda K; Kajitani K; Nobeyama H; Kira Y; Yabunaka Y; Egami M; Zhi X; Fukuda T; Yoshida H; Matsumoto Y; Ichimura T; Yaui T; Sumi T; Ishiko O
Asian Pac J Cancer Prev; 2011; 12(4):865-8. PubMed ID: 21790217
[TBL] [Abstract][Full Text] [Related]
18. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
[TBL] [Abstract][Full Text] [Related]
19. The Cdkn1a
Torgovnick A; Heger JM; Liaki V; Isensee J; Schmitt A; Knittel G; Riabinska A; Beleggia F; Laurien L; Leeser U; Jüngst C; Siedek F; Vogel W; Klümper N; Nolte H; Wittersheim M; Tharun L; Castiglione R; Krüger M; Schauss A; Perner S; Pasparakis M; Büttner R; Persigehl T; Hucho T; Herter-Sprie GS; Schumacher B; Reinhardt HC
Cell Rep; 2018 Oct; 25(4):1027-1039.e6. PubMed ID: 30355482
[TBL] [Abstract][Full Text] [Related]
20. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants.
Tada M; Furuuchi K; Kaneda M; Matsumoto J; Takahashi M; Hirai A; Mitsumoto Y; Iggo RD; Moriuchi T
Carcinogenesis; 2001 Mar; 22(3):515-7. PubMed ID: 11238194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
